OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 13, 2017
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
November 10, 2017
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.
November 09, 2017
The company has officially opened a local brand office in South Korean to support its existing business in the region.
November 03, 2017
The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
November 02, 2017
Data governance is necessary for compliance with current regulatory expectations for data integrity in pharmaceutical R&D and manufacturing organizations.
Almac Group will acquire BioClin Laboratories to expand Almac’s analytical service offerings.
Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.